ubiquitous calpain whose expression level and subcellular distribution is dynamically influenced by calcium.
Introduction
Calpains represent a superfamily of structurally-related, intracellular, calcium-activated, nonlysosomal, cysteine proteases (1-2). The typical four domain structure of the catalytic subunit is comprised of Domain I (autolytic activation), Domain II (cysteine catalytic site), Domain III ("electrostatic switch"), and Domain IV (calmodulin-like, calcium binding sites) (3, 4) .
Calpains showing this structural format include the ubiquitous m-and µ-calpains (5); and some tissue-preferred calpains, such as calpain 3 -also termed p94 (6), stomach nCl-2 (7), digestive tubule nCl-4, lens Lp82 and Lp85 (8) (9) , and retina Rt88 (10) .
Recently, atypical calpains including calpains 5, 6 and 10 have been described, where certain domains have been replaced or deleted (11) (12) (13) (14) . Calpain 10 is especially interesting because the calmodulin domain was replaced with a divergent "T" domain containing no calcium-binding EF hand structures. TRA-3, an atypical calpain from C. elegans likewise has the "T" domain replacement, yet TRA-3 exhibited Ca 2+ -dependent protease activity (15) .
Transcripts for calpain 10 were ubiquitously found in many human (16) and mouse (17) tissues examined. This raised the real possibility that most tissues contain a calpain that either does not need calcium for activity, or it uses an activation mechanism different from the traditional calpains. Furthermore, Horikawa et al. (16) recently used positional cloning to discover that genetic variation in the calpain 10 gene was associated with increased risk for type 2 diabetes mellitus in certain human population groups. Alternative splicing may generate at least eight forms of calpain 10, some of which would also lack the protease domain. Altered expression of calpain 10 enzyme in pancreatic, muscle and fat cells was postulated to lead to abnormal glucose homeostasis because of modification in an unknown, calpain 10-dependent pathway.
To our knowledge, nothing is known about protein expression or cellular localization of calpain 10, or if calpain 10 is altered under conditions of elevated cellular calcium. Such data would be important for understanding the mechanism of action of calpain 10 in both normal and disease conditions. Thus, the experiments reported below developed and used an antibody to measure calpain 10 protein expression in normal human, rat and mouse tissues as well as in cultured lens epithelial cells and experimental cataract where cellular calcium was elevated.
Experimental cataract was used because it is a well documented example of excessive calpain activity leading to a pathologic condition (18) .
EXPERIMENTAL PROCEDURES
Animals, Tissue Collection, and RNA Isolation . All animals were handled in compliance with the "Guiding Principles in Care and Use of Animals (DHEW Publication, NIH 86-23). To produce nuclear cataract in rats, a single subcutaneous injection of sodium selenite at 30 µmoles/kg body weight was administered to 12 day old Sprague-Dawley rats (B & K International, Fremont, CA) as previously described (18) . Lenses were subsequently removed by a posterior approach, and lens capsule/epithelium dissections were performed under a dissecting microscope (16X) by removing the capsule with adhering epithelium. Ten preparations were pooled to obtain sufficient material. The interface between the cortex and nucleus of the remaining lens mass was determined by the appearance of cold cataract, and cortical and nuclear regions were dissected at approximately 50 % of the lens radius. All lens and soft tissues were chilled throughout the dissection to prevent breakdown of RNA. After homogenization in TRIzol reagent (Life Technologies, NY, USA) at 1 ml/100 mg tissue, RNA was extracted according to the manufacturer's instructions. Total RNA was then treated with DNAse to remove genomic DNA, and quantitation was performed spectrophotometrically.
cDNA Cloning of Rat Calpain 10. PCR cloning was performed on rat lens total RNA. Based upon the cDNA sequence for mouse calpain-like protease formerly named calpain 8 (17) , the PCR primers used to amplify the partial rat calpain 10 cDNA were: upstream 5'-GAA GGG GAG CCC AGG GCG CCG AAG ATG-3', and downstream 5'-GCA GTG TTG CTG TAG GGT GAT ACG GAT G-3'. Five micrograms of lens RNA were reverse-transcribed using oligo-dT primer and SuperScript II reverse transcriptase (Life Technologies). Reverse Preparation of Antibody for Calpain 10 -Antibody for calpain 10 for potential use with rat, mouse, and human samples was generated by first chemically synthesizing the peptide, WSLKDIRKASGQQDRPSGGE, which corresponds to a 20-amino acid sequence in domain II of rat calpain 10 ( Fig. 2A) . The similarity of the rat immunogenic peptide to the sequence in mouse and human calpain 10 was 90 % and 50 %, respectively; with 100% similarity among all three species for a shorter amino acid sequence predicted to be surface epitopes (underlined in the peptide sequence above) . The peptide was HPLC purified, and conjugated to keyhole limpet hemocyanin by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide conjugation (TriplePoint Biologics, Portland, OR,USA). The first immunization was with Freund's complete adjuvant, and subsequent immunizations were at four-week intervals with Freund's incomplete adjuvant.
Rabbits were anaesthetized and exsanguinated, and the antibody was purified from serum using the peptide bound to Aminolink resin (Pierce, Rockford, IL,USA). The antibody gave positive staining after immunoblotting and/or immunohistochemistry against rat, mouse, and human tissues; an αTN4-1 mouse cell line; and recombinant mouse calpain 10 over expressed in insect cells (discussed below). The antibody did not cross react with rat Lp82 calpain or m-calpain on immunoblots (data not shown), suggesting that the antibody possessed significant specificity for calpain 10. For immunofluorescence with cell lines, maintenance and preparation of the αTN4-1 cells were followed as described previously (20) . Fig. 2A) . Domain II contained the Cys-, His-and Asnresidues found in the active site of other calpain catalytic subunits (1-2). The divergent Cterminal domain ("T") showed no significant similarity to the calmodulin-like Ca-binding domain IV of the traditional calpains. The overall similarity of rat calpain 10 with the catalytic subunit of ubiquitous m-calpain was only 15%, and the similarity with lens specific calpain Lp82 was 18%.
Preparation of Total Protein Extract
Expression of calpain 10. RT-PCR revealed that calpain 10 transcripts were ubiquitously expressed in all rat tissues examined (Fig. 1A) . The highest level of expression in young rat was in brain and the lowest was in spleen while in adult human heart was the highest (16) . Lens was studied in detail in the present experiments as an example of a terminally differentiated tissue with very little protein turnover in the center (nucleus) during the lifetime of the host (21). mRNA for calpain 10 was detected in all lens regions with the most abundant in the outer region of lens epithelium (Fig. 1B) . The oldest portion of the lens, the inner nucleus region, showed the lowest level of mRNA for calpain 10. The cDNA sequence was shown to be a translatable message because insect cells infected with the mouse cDNA over expressed recombinant calpain 10 in the soluble and insoluble fractions at the expected 78.8 kDa position (extra 36 amino acids on the N-terminus of the recombinant protein) ( Fig 2B, lanes 4 & 5, solid arrow) . The lower immunoreactive band was presumed to be endogenous calpain 10 because it migrated at the expected size of 74.5 kDa for native calpain 10, and it was ubiquitously expressed in infected as well as non-infected cells (lanes 2 & 3) . Immunoblotting also confirmed that calpain 10 transcripts were ubiquitously translated in tissues from young rats and that the protein was stable (Fig. 3, lanes 1 -10) . Two protein bands were present in most tissues near the expected size of 74.5 kDa (arrows). In these tissues, a large fraction of the calpain 10 protein was not readily soluble in aqueous buffers (data not shown). The full-length cDNA of mouse calpain 10 was also subcloned into the pcDNA 3.1 vector for transient expression in COS-7 cells.
Preliminary results showed two similar immunoreactive bands (data not shown).
Immunoblotting also identified calpain 10 orthologues in human lenses (Fig. 4) . Young human lens showed immunopositive proteins near 74.5 kDa in both the soluble and insoluble lens proteins. Appreciable levels of immunostaining staining were found only in young lenses up to 3 years of age. Calpain 10 proteins were not detectable in aged human lenses (69 through 85 year old). These results suggested that calpain 10 protein expression was associated with developing lens and then lost with aging.
Localization of calpain 10.
Immunohistochemistry with the calpain 10 antibody revealed that calpain 10 was located mainly in the cytoplasm of the epithelium and transition zone of the newborn mouse lens (Fig. 5 A & B) , while the primary and secondary fibers in the cortex and nucleus showed much lower levels. Calpain 10 in human lens was also concentrated in the lens epithelium ( Fig. 5 C & D) . However, in the outer fiber cells of human lens, calpain 10 was concentrated at the plasma membranes (Fig 5 C, arrow head) . Similarly, calpain 10 immunoreactivity was predominantly found at the sarcolemma in skeletal muscle fibers from young mice (Fig. 5E, arrow head) . Note that because not all of the immunopositive bands on immunoblots with calpain have been positively identified, we cannot exclude the possibility that the antibody may be labeling other proteins in addition to calpain 10.
Calpain 10 in cultured αTN4-1 mouse lens epithelial cells was not only present in the cytosol, but also in the nucleus in a punctate arrangement (Fig. 6B) . Double staining of this region for both calpain 10 and DNA showed that calpain 10 was not associated with DNA in the nucleus (Fig. 6C) . The nuclear localization of calpain 10 was further confirmed by a Z-series analysis with the confocal microscope, which showed that calpain 10 was partially localized in the nucleus in micro compartments (data not shown). These observations agree with the computer-aided PSORT analysis for nuclear localization signals (NLS). The predicted calpain 10 gene product showed a characteristic NLS of + 0.46 located in domain III. This was in contrast to the NLS score of -0.10 for m-calpain, which accumulated only in the cytoplasm of αTN4-1 mouse cells (20) . As noted above, some of the immunostaining may be due to non-calpain proteins, but the observations suggested that the calpain 10 may function by association with nuclear proteins. Interestingly, elevation of intracellular calcium with 10 µM ionomycin caused decreased staining in the cytoplasm and increased staining in the nucleus (Fig. 6E & F) .
Changes in calpain 10 during experimental cataract formation. Selenite nuclear cataract model was used to further investigate the influence of massive increases in cellular calcium on calpain 10. The concentration of calcium in the nuclear region of lenses with selenite cataract is known to reach over 100 µM free calcium compared to 0.2 uM for the normal nucleus (18) . mRNA levels for calpain 10 increased in outer regions (epithelium and cortex) of lens during selenite cataract formation (Fig. 7A) . Calpain 10 protein levels in rat lens in the epithelium (Fig. 7B ) of selenite cataract decreased after day 3, while in nucleus (Fig. 7C) calpain 10 was already lost by day 3 when the cataract appeared. Thus, calpain 10 transcripts were rapidly upregulated in the outer regions of the lens during nuclear cataract formation, but calpain 10 protein was degraded when cataract was present.
DISCUSSION

Calpain 10 protein in tissues.
The data presented above provide the first evidence for the expression of the protein for calpain 10 in mouse, rat, and human tissues. This was important because previous publications demonstrated transcription of the calpain 10 gene (14, 16, 22) , but no data have been provided until now that calpain 10 was actually translated in tissues. Our immunoblotting data demonstrated that calpain 10 protein was indeed ubiquitously expressed in all tissues examined.
Calpain 10 is thus the 3 rd ubiquitous calpain in tissues along with m-and u-calpains. Most rat tissues showed at least two major proteins bands near the expected 74.5 kDa predicted by the cDNA calpain 10. The highest concentration of calpain 10 was in the water insoluble fraction of tissues, suggesting that a significant portion of cellular calpain 10 may be insoluble in the cytosol or associated with membranes or cytoskeletal elements.
Variability of calpain 10 expression patterns in normal tissues
Calpain 10 protein expression varied with the particular tissue. Young lens was dominated by two proteins, while retina showed at least four protein bands. This variability was interesting because Horikawa et al. (16) hypothesized that polymorphism in the calpain 10 gene contributed to the genetic susceptibility to diabetes type 2 in certain human population groups. In our studies, at least four factors may be responsible for variable calpain 10 expression patterns: 1) Protein degradation and autolysis. The traditional calpains are well-known to undergo autolysis and degradation after calcium activation or aging (1) (2) . Recent studies also show that calpains are even substrates for each other after activation by calcium (unpublished observations). 2) Aging.
Advancing age was associated with major losses in calpain 10 protein levels. Very little calpain 10 was present in the lenses of mature human and rat lenses, and the oldest regions of the rat lens, the nucleus, also contained the lowest concentration of calpain 10 protein. In contrast, the high level of calpain 10 observed in the outer regions of lens may be needed for proteolysis occurring in this region during cell remodeling for terminal differentiation of lens fiber cells.
This extensive remodeling is characterized by conversion of outer cuboidal epithelial cells to long fibers with concomitant loss of all organelles as the fibers are pushed into the interior of the lens. Our results suggested that calpain 10 protein expression was associated with developing lens cells and then lost with aging. 3) mRNA processing. Eight splice variants of calpain 10 gene were identified in man (16) , and potentially at least five of these could be recognized by our antibody. Furthermore, two lens-specific, splice variants Lp82 and Lp85 of calpain 3 were found in rodent lenses (8, 9) . Thus, some of the multiple forms of calpain 10 observed in normal tissues may be splice variants generated by alternative exon usage. 4) Non-specific immunostaining is also possible and the various calpain 10 bands need to be sequenced. Future studies will be needed to determine if calpain 10 specific proteins are associated with different functions or increased susceptibility to diseases.
Response of calpain 10 to calcium.
In order to understand the function of calpain 10 in pathologic conditions, we also tested if calpain 10 was responsive to increases in cellular calcium using two model systems. 1) Selenite cataract. Selenite cataract is caused by a well-documented mechanism involving calcium accumulation in the nuclear region of the lens and proteolysis of the structural proteins called crystallins by m-calpain and Lp82 (23) (24) . Like m-calpain (25) , calpain 10 transcripts increased rapidly in the outer regions of young rat lens 24 hours after selenite injection before onset of nuclear cataract. This observation may be due to up-regulation in response to increased calpain 10 activity or due to another calpain 10-dependent processes such as signal transduction.
Apoptosis was also increased in selenite cataract (26) , and calpain 10 may influence apoptosis by controlling IkBa turnover, similar to that proposed for calpain 3 (27) . 
